Narnatumab ? Monoclonal antibody Type Whole antibody Source Mouse Target CD22 Clinical data Pregnancy cat. ? Legal status ? Identifiers CAS number ATC code None Chemical data Formula C6454H10026N1754O2020S44 Mol. mass 145.9 kDa (what is this?)
Narnatumab is a human monoclonal antibody designed for the treatment of cancer.
Narnatumab was developed by ImClone Systems.
- ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Narnatumab". American Medical Association. http://www.ama-assn.org/resources/doc/usan/narnatumab.pdf.
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.